PrintThe Burrill Report
April 08, 2010
http://www.burrillreport.com/article-an_open_window.html
INITIAL PUBLIC OFFERINGS
An Open Window
Life Sciences companies that have gone public since August 2009.[Please login to post comments]
- A Hammer in Search of a Nail
DEA grows impatient with the pace at which the FDA addresses opioid abuse. Read More - Actavis Buys Warner Chilcott
Combination will create a tax-advantaged global specialty pharma. Read More - Gates Foundation Helps Repurpose Exubera Technology
Monash Institute of Pharmaceutical Sciences receives more than $1 million for drug delivery development. Read More - Industry Advocates Ally to Lobby for Tax Reforms
New group draws together BIO, AdvaMed, and others seeking tax code changes. Read More - Elan Strikes More Deals, Rejects Sweetened Royalty Pharma Bid
Pharma moves to acquire two companies, spin out a program, and issue debt. Read More - What Wall Street's Watching at ASCO
Podcast: May 28, 2013 Read More - Stem Cell Policy Group Folds Tent
Coalition for the Advancement of Medical Research transfers mission and assets to Alliance for Regenerative Medicine. Read More - GSK and BARDA Collaborate to Develop New Antibiotics
The $200M deal seeks to create a pipeline of new drugs. Read More - Pfizer Drug Fails Three Late-stage Trials
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Obama Administration Offers $1 Billion for Healthcare Innovation
HHS awards designed to transform delivery and payment systems. Read More
.gif)
.png){kind=small} |
 |